The paperwork for the disastrous drug trial that has left six men in intensive care, two of them still in a critical condition, did not contain anything to give cause for concern, the regulator for approving clinical trials has said.

The Medical and Healthcare products Regulatory Agency said its inquiry into the extreme adverse reaction suffered by the volunteers would take several weeks.